Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2 - PubMed (original) (raw)
Comparative Study
. 2003 Dec;23(12):745-56.
doi: 10.1089/107999003772084860.
Affiliations
- PMID: 14769151
- DOI: 10.1089/107999003772084860
Comparative Study
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2
Douglas W Leaman et al. J Interferon Cytokine Res. 2003 Dec.
Abstract
Interferon (IFN)-dependent cellular effects are mediated by transcriptional induction of responsive genes, collectively referred to as IFN-stimulated genes (ISGs). Which ISGs regulate the potent antiviral, antiproliferative, apoptosis-inducing, antiangiogenic, and immunologic effects of IFNs remains largely undetermined. To identify genes that might be useful for predicting or targeting apoptosis induction in response to IFNs, WM9 melanoma cells were assessed. WM9 cells had equivalent antiviral activity in response to IFN-beta and IFN-alpha2 but underwent apoptosis only in response to IFN-beta. RNA samples from WM9 cells and WM35 cells, a second melanoma cell line, treated with IFN-alpha2 or IFN-beta were assessed on oligonucleotide arrays. For 95% of genes assessed, IFN-beta was more potent than IFN-alpha2 in inducing ISG expression. Using a 22,000-gene oligonucleotide array, the largest yet reported for assessing ISG induction, approximately 910 genes were identified as induced by IFN-beta at 500 U/ml, and 260 ISGs were identified as significantly induced by IFN-beta at both 50 and 500 U/ml. Of these 260, 209 were defined as new ISGs based on the array analysis. Confirmation by Northern blot or semiquantitative or quantitative PCR was undertaken for 28, and all were confirmed. Nearly half of the 260 genes were functionally categorized as encoding growth-regulatory proteins. Of the 104 with described growth-regulatory function, 71 were induced more than three times by 500 U/ml and twice by 50 U/ml IFN-beta, and 48 of these were new ISGs. Included in this latter category were tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), XIAP-associated factor 1 (XAF1), galectin 9, a cyclin E binding protein, amphiphysin 1, MyD88, and several ubiquitin pathway genes. The diversity of stimulated genes suggests the full therapeutic potential of IFN regulation of gene expression has yet to be realized.
Similar articles
- Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC. Reu FJ, et al. Cancer Res. 2006 Mar 1;66(5):2785-93. doi: 10.1158/0008-5472.CAN-05-2303. Cancer Res. 2006. PMID: 16510600 Free PMC article. - IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC. Chawla-Sarkar M, et al. J Immunol. 2002 Jul 15;169(2):847-55. doi: 10.4049/jimmunol.169.2.847. J Immunol. 2002. PMID: 12097388 - Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.
Borden EC. Borden EC. Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):491-501. doi: 10.1016/j.cytogfr.2007.06.022. Epub 2007 Aug 6. Cytokine Growth Factor Rev. 2007. PMID: 17689283 Free PMC article. Review. - Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.
Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. Chawla-Sarkar M, et al. Apoptosis. 2003 Jun;8(3):237-49. doi: 10.1023/a:1023668705040. Apoptosis. 2003. PMID: 12766484 Review.
Cited by
- Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.
Coelho LF, Magno de Freitas Almeida G, Mennechet FJ, Blangy A, Uzé G. Coelho LF, et al. Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11917-22. doi: 10.1073/pnas.0502188102. Epub 2005 Aug 4. Proc Natl Acad Sci U S A. 2005. PMID: 16081539 Free PMC article. - Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6).
Grünvogel O, Esser-Nobis K, Windisch MP, Frese M, Trippler M, Bartenschlager R, Lohmann V, Binder M. Grünvogel O, et al. Genom Data. 2015 Dec 28;7:166-70. doi: 10.1016/j.gdata.2015.12.017. eCollection 2016 Mar. Genom Data. 2015. PMID: 26981398 Free PMC article. - Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.
Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE. Medrano RFV, et al. Oncotarget. 2017 Jul 25;8(41):71249-71284. doi: 10.18632/oncotarget.19531. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050360 Free PMC article. Review. - Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3.
Rabbani MA, Ribaudo M, Guo JT, Barik S. Rabbani MA, et al. J Virol. 2016 Nov 28;90(24):11145-11156. doi: 10.1128/JVI.01551-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27707917 Free PMC article. - ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells.
Liu N, Wu Z, Chen A, Chai D, Li L, Zhang L, Zheng J. Liu N, et al. J Cell Mol Med. 2019 May;23(5):3520-3529. doi: 10.1111/jcmm.14251. Epub 2019 Mar 1. J Cell Mol Med. 2019. PMID: 30821058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials